CANBRIDGE PHARMACEUTICALS INC financial statements, including revenue, expenses, profit, and loss

The total revenue of 1228 for the last semiannual is 48.54 M HKD, and it's 24.89% lower compared to the previous semiannual. The net income of H1 24 is -267.95 M HKD.